NetworkNewsBreaks – MCTC Holdings Inc. (MCTC) Ex
Post# of 112
(Total Views: 134)
Posted On: 11/20/2019 3:41:16 PM
NetworkNewsBreaks – MCTC Holdings Inc. (MCTC) Expands Research & Development Program
Los Angeles, California-based MCTC Holdings (OTC: MCTC) this morning announced that it is expanding its research and development (“R&D”) program designed to produce polymeric nanoparticles of cannabinol (“CBN”). The expansion aims to create nanoparticles of cannabinoid glycosides, which the company believes will hold considerable commercial viability in the future. MCTC’s research team plans to produce CBN nanoparticles with both immediate and controlled-release properties based on the company’s experience producing cannabidiol (“CBD”) nanoparticles and nanofibers. MCTC also added the creation of nanoparticles of cannabinoid glycosides to its research program. “We are continuing our R&D programs based on three primary goals,” MCTC CEO Arman Tabatabaei stated in the news release. “First, we plan to continue toward mass production of immediate and controlled-release CBD nanoparticles and, to a lesser extent, CBD nanofibers. Second, we plan to utilize this experience to replicate the process using some of the minor cannabinoids, with CBN selected as the first target. Lastly, we are focusing all of our research toward protecting the intellectual property we develop. Thus far, we have filed four patents, with one additional application in progress. We are likely to file several more patent applications over the coming months as our cannabinoid R&D programs progress.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Los Angeles, California-based MCTC Holdings (OTC: MCTC) this morning announced that it is expanding its research and development (“R&D”) program designed to produce polymeric nanoparticles of cannabinol (“CBN”). The expansion aims to create nanoparticles of cannabinoid glycosides, which the company believes will hold considerable commercial viability in the future. MCTC’s research team plans to produce CBN nanoparticles with both immediate and controlled-release properties based on the company’s experience producing cannabidiol (“CBD”) nanoparticles and nanofibers. MCTC also added the creation of nanoparticles of cannabinoid glycosides to its research program. “We are continuing our R&D programs based on three primary goals,” MCTC CEO Arman Tabatabaei stated in the news release. “First, we plan to continue toward mass production of immediate and controlled-release CBD nanoparticles and, to a lesser extent, CBD nanofibers. Second, we plan to utilize this experience to replicate the process using some of the minor cannabinoids, with CBN selected as the first target. Lastly, we are focusing all of our research toward protecting the intellectual property we develop. Thus far, we have filed four patents, with one additional application in progress. We are likely to file several more patent applications over the coming months as our cannabinoid R&D programs progress.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)